Market access roundup: Government grillings for Vertex and US pharmaIt was a month characterised by governments butting heads with pharma over pricing both in the UK and Share XMarket access roundup: Government grillings for Vertex and US pharmahttps://pharmaphorum.com/views-analysis-market-access/market-access-roundup-government-grillings-vertex-us-pharma-pricing/
Realising the potential of wearable techSpire Health, a US-based continuous respiration sensing and high-adherence ambulatory monitoring healthcare company, is poised to revolutionise the Share XRealising the potential of wearable techhttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/spire-health-clinical-trial-wearables/
The great regulatory catch-upMedical device manufacturers have a lot to learn from the pharmaceutical sector which, for well over a decade, Share XThe great regulatory catch-uphttps://pharmaphorum.com/views-analysis-market-access/great-regulatory-medical-device/
The shadow of Brexit on speed of accessNo-one can miss the ongoing saga that is the UK’s exit from the European Union (EU). The uncertainties Share XThe shadow of Brexit on speed of accesshttps://pharmaphorum.com/views-analysis-market-access/the-shadow-of-brexit-on-speed-of-access/
Eyeforpharma Barcelona 2019 roundupThis year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting Share XEyeforpharma Barcelona 2019 rounduphttps://pharmaphorum.com/digital/eyeforpharma-barcelona-2019-roundup/
Rethinking drug discoveryGeorge Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change. Share XRethinking drug discoveryhttps://pharmaphorum.com/r-d/views-analysis-r-d/rethinking-drug-discovery/
Precision medicine: AZ’s Ruth March on its next stepsAstraZeneca’s senior vice-president and head of precision medicine, research & development, Ruth March, has been central to the Share XPrecision medicine: AZ’s Ruth March on its next stepshttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/astrazeneca-ruth-march-precision-medicine/
R&D round-up: Non-opioid painkiller space heats upAs the MHRA announced that it would be convening an Expert Working Group (EWG) to assess the risks Share XR&D round-up: Non-opioid painkiller space heats uphttps://pharmaphorum.com/views-and-analysis/rd-roundup-non-opioid-painkiller-space-heats-up/
Innovating in clinical trial recruitmentClinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients Share XInnovating in clinical trial recruitmenthttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/havas-lynx-faze-clinical-trials/
